FLUGEN, INC.
Transforming vaccine efficacy in respiratory disease.
Transforming vaccine efficacy in respiratory disease.
FLUGEN, INC. is a clinical-stage vaccine company founded in 2007 with a mission to transform vaccine efficacy in respiratory diseases. The company's slogan, "Transforming vaccine efficacy in respiratory disease." encapsulates its core focus. Specializing in the Biotechnology, Health Care, and Pharmaceutical industries, Flugen, Inc. has recently received a significant $11.40M grant investment on 01 July 2021 from the U.S. Department of Defense.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Grant | $11.40M | 1 | U.S. Department of Defense | 01 Jul 2021 |
| Debt Financing | $5.60M | - | 25 Nov 2018 | |
| Grant | $14.40M | - | 18 Oct 2017 | |
| Debt Financing | $5.50M | - | 01 Aug 2017 | |
| Series A | $2.00M | 4 |
|
11 Apr 2017 |
No recent news or press coverage available for FLUGEN, INC..
We care about your data, and we'd love to use cookies make your experience better.
